RWE

Views & Analysis

Real world evidence, digital partnerships and the future of ...

Ahead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & alliances, global medical affairs – about why collaboration and RWE

Views & Analysis

Transforming oncology with a pan-European approach to data s...

Between genomic data, electronic health records and digital health tools, we have all the information we need to transform the fortunes of people living with cancer – but how do we ensure i

Views & Analysis

Nine for 2019 Challenges impacting pharma

Nine for 2019: Opportunities for pharma

In the last Nine for 2019 article, we reflected on the major challenges that are sha

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen announces first data centres for haematology network

Janssen has announced the first two data centres to join its HONEUR (Haematology Outcome

Views & Analysis

Harnessing RWE in rare diseases

Ahead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to us about the importance of collaboration and RWE to he

Views & Analysis